Literature DB >> 26380941

Using Peptide-Level Proteomics Data for Detecting Differentially Expressed Proteins.

Tomi Suomi, Garry L Corthals1, Olli S Nevalainen, Laura L Elo.   

Abstract

The expression of proteins can be quantified in high-throughput means using different types of mass spectrometers. In recent years, there have emerged label-free methods for determining protein abundance. Although the expression is initially measured at the peptide level, a common approach is to combine the peptide-level measurements into protein-level values before differential expression analysis. However, this simple combination is prone to inconsistencies between peptides and may lose valuable information. To this end, we introduce here a method for detecting differentially expressed proteins by combining peptide-level expression-change statistics. Using controlled spike-in experiments, we show that the approach of averaging peptide-level expression changes yields more accurate lists of differentially expressed proteins than does the conventional protein-level approach. This is particularly true when there are only few replicate samples or the differences between the sample groups are small. The proposed technique is implemented in the Bioconductor package PECA, and it can be downloaded from http://www.bioconductor.org.

Keywords:  PECA; differential expression; label-free; peptide-level; protein-quantification.

Mesh:

Substances:

Year:  2015        PMID: 26380941     DOI: 10.1021/acs.jproteome.5b00363

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  18 in total

1.  The histone methyltransferase EZH2 is a therapeutic target in small cell carcinoma of the ovary, hypercalcaemic type.

Authors:  Yemin Wang; Shary Yuting Chen; Anthony N Karnezis; Shane Colborne; Nancy Dos Santos; Jessica D Lang; William Pd Hendricks; Krystal A Orlando; Damian Yap; Friedrich Kommoss; Marcel B Bally; Gregg B Morin; Jeffrey M Trent; Bernard E Weissman; David G Huntsman
Journal:  J Pathol       Date:  2017-06-02       Impact factor: 7.996

2.  Histone Deacetylase Inhibitors Synergize with Catalytic Inhibitors of EZH2 to Exhibit Antitumor Activity in Small Cell Carcinoma of the Ovary, Hypercalcemic Type.

Authors:  Yemin Wang; Shary Yuting Chen; Shane Colborne; Galen Lambert; Chae Young Shin; Nancy Dos Santos; Krystal A Orlando; Jessica D Lang; William P D Hendricks; Marcel B Bally; Anthony N Karnezis; Ralf Hass; T Michael Underhill; Gregg B Morin; Jeffrey M Trent; Bernard E Weissman; David G Huntsman
Journal:  Mol Cancer Ther       Date:  2018-09-19       Impact factor: 6.261

3.  A Bayesian Null Interval Hypothesis Test Controls False Discovery Rates and Improves Sensitivity in Label-Free Quantitative Proteomics.

Authors:  Robert J Millikin; Michael R Shortreed; Mark Scalf; Lloyd M Smith
Journal:  J Proteome Res       Date:  2020-04-14       Impact factor: 4.466

4.  Oncogenic KRAS and BRAF Drive Metabolic Reprogramming in Colorectal Cancer.

Authors:  Josiah E Hutton; Xiaojing Wang; Lisa J Zimmerman; Robbert J C Slebos; Irina A Trenary; Jamey D Young; Ming Li; Daniel C Liebler
Journal:  Mol Cell Proteomics       Date:  2016-06-23       Impact factor: 5.911

5.  Detecting differential protein abundance by combining peptide level P-values.

Authors:  Bryan J Killinger; Vladislav A Petyuk; Aaron T Wright
Journal:  Mol Omics       Date:  2020-09-14

6.  Quantitative Profiling of Single Formalin Fixed Tumour Sections: proteomics for translational research.

Authors:  Christopher S Hughes; Melissa K McConechy; Dawn R Cochrane; Tayyebeh Nazeran; Anthony N Karnezis; David G Huntsman; Gregg B Morin
Journal:  Sci Rep       Date:  2016-10-07       Impact factor: 4.379

7.  Covariation of Peptide Abundances Accurately Reflects Protein Concentration Differences.

Authors:  Bo Zhang; Mohammad Pirmoradian; Roman Zubarev; Lukas Käll
Journal:  Mol Cell Proteomics       Date:  2017-03-16       Impact factor: 5.911

8.  HIF prolyl hydroxylase PHD3 regulates translational machinery and glucose metabolism in clear cell renal cell carcinoma.

Authors:  Heidi Högel; Krista Rantanen; Petra Miikkulainen; Tomi Suomi; Petri Kouvonen; Laura L Elo; Panu M Jaakkola
Journal:  Cancer Metab       Date:  2017-07-04

9.  Selective aggregation of the splicing factor Hsh155 suppresses splicing upon genotoxic stress.

Authors:  Veena Mathew; Annie S Tam; Karissa L Milbury; Analise K Hofmann; Christopher S Hughes; Gregg B Morin; Christopher J R Loewen; Peter C Stirling
Journal:  J Cell Biol       Date:  2017-10-04       Impact factor: 10.539

10.  Enhanced differential expression statistics for data-independent acquisition proteomics.

Authors:  Tomi Suomi; Laura L Elo
Journal:  Sci Rep       Date:  2017-07-19       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.